Using Esterase Selectivity to Determine the In Vivo Duration of Systemic Availability and Abolish Systemic Side Effects of Topical β-Blockers.

Autor: Baker, Jillian G., Fromont, Christophe, Bruder, Marjorie, Thompson, Kevin S. J., Kellam, Barrie, Hill, Stephen J., Gardiner, Sheila M., Fischer, Peter M.
Zdroj: ACS Pharmacology & Translational Science; 8/14/2020, Vol. 3 Issue 4, p737-748, 12p
Databáze: Supplemental Index